WO2023175526 - PROCESS FOR PREPARATION OF AZABICYCLO [3.1.0] HEXANE INTERMEDIATES

National phase entry is expected:
Publication Number WO/2023/175526
Publication Date 21.09.2023
International Application No. PCT/IB2023/052509
International Filing Date 15.03.2023
Title **
[English] PROCESS FOR PREPARATION OF AZABICYCLO [3.1.0] HEXANE INTERMEDIATES
[French] PROCÉDÉ DE PRÉPARATION D'INTERMÉDIAIRES AZABICYCLO[3.1.0]HEXANE
Applicants **
LAURUS LABS LIMITED
Inventors
MEKALA, Naga Raju
LAGADAPATI, Srinivasa Rao
KOLA, Lakshmi Kanth
SHAIK, Firoz
BASINENI, Pedda Reddaiah
BARIK, Prasant Kumar
GALLA, Tirumala Rao
NADELLA, Madhu Murthy
SIMHADRI, Srinivas
VASIREDDI, Uma Maheswer Rao
Priority Data
202241014235   16.03.2022   IN
202241020524   05.04.2022   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
译文

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting3135
EPO Filing, Examination, Granting27687
Japan Filing, Examination, Granting3112
South Korea Filing, Examination, Granting4231
USA Filing, Examination, Granting11740
MasterCard Visa
Total: 49,905

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present invention generally relates to a process for preparation of azabicyclo [3.1.0] hexane intermediate of Formula (I), an intermediate for preparation of certain antiviral compounds for example boceprevir and nirmatrelvir. Wherein "R1" is selected from hydrogen, alkyl, aryl or aralkyl.[French] La présente invention concerne de manière générale un procédé de préparation d'intermédiaire azabicyclo[3.1.0]hexane de formule (I), un intermédiaire pour la préparation de certains composés antiviraux, par exemple le bocéprévir et le nirmatrelvir. Dans la formule,"R1" est choisi parmi hydrogène, alkyle, aryle ou aralkyle.